Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   

The Angels Initiative

Stroke prevention

  Hypersensitivity Reaction

  Free Subscription


1 Acta Derm Venereol
4 Allergy
10 Ann Allergy Asthma Immunol
2 Contact Dermatitis
1 Dermatology
1 Eur Respir J
2 Int Arch Allergy Immunol
1 J Allergy Clin Immunol
1 J Dermatol

  Retrieve available abstracts of this week’s articles:
HTML format
Single Articles

    Acta Derm Venereol

  1. OSAWA K, Kiniwa Y, Shimosato Y, Midorikawa H, et al
    Toxic Epidermal Necrolysis Caused by Apalutamide: A Case Report of Treatment Using Etanercept with Conventional Steroid Therapy.
    Acta Derm Venereol. 2022;102:adv00723.


  2. ASHLEY SE, Jones AC, Anderson D, Holt PG, et al
    Remission of peanut allergy is associated with rewiring of allergen-driven T helper 2-related gene networks.
    Allergy. 2022 May 25. doi: 10.1111/all.15324.
    PubMed         Abstract available

  3. FERNANDEZ-SANTAMARIA R, Bogas G, Montanez MI, Ariza A, et al
    Synthetic antigenic determinants of clavulanic acid induce dendritic cell maturation and specific T cell proliferation in patients with immediate hypersensitivity reactions.
    Allergy. 2022 May 24. doi: 10.1111/all.15383.
    PubMed         Abstract available

  4. GRAHAM F, Fiocchi A
    The importance of threshold dose-distribution data for priority allergens and the need for future studies.
    Allergy. 2022 May 24. doi: 10.1111/all.15387.

  5. ANDIAPPAN AK, Puan KJ, Sio YY, Ally F, et al
    Functional CTLA-4 variants associate to both allergic asthma and rhinitis potentially by modulating naive regulatory T cells.
    Allergy. 2022 May 24. doi: 10.1111/all.15386.

    Ann Allergy Asthma Immunol

  6. SHERREY J, Biggs S, Dorrian J, Martin J, et al
    Allergic disease, sleep problems and psychological distress in children recruited from the general community.
    Ann Allergy Asthma Immunol. 2022 May 19. pii: S1081-1206(22)00409.
    PubMed         Abstract available

  7. CLAIR BDS, Hoffman DL, McClenathan B, Banks T, et al
    Outcomes of Allergic Type Reactions Following mRNA COVID-19 Vaccination at Three Military Medical Centers.
    Ann Allergy Asthma Immunol. 2022 May 19. pii: S1081-1206(22)00442.

  8. CHIANG V, Saha C, Yim J, Au E, et al
    Allergists and COVID-19 Vaccine Allergy Safety: A Pilot Study "Hub-and-Spoke" Model for Population-Wide Allergy Service.
    Ann Allergy Asthma Immunol. 2022 May 20. pii: S1081-1206(22)00443.
    PubMed         Abstract available

  9. COREY KB, Koo G, Stone CA Jr, Kroop SF, et al
    The role of anti-polyethylene glycol (PEG) IgM, IgG, or IgE antibodies in COVID mRNA vaccine anaphylaxis is unknown. We highlight a case with preexisting anti-PEG antibodies that tolerated vaccination.
    Ann Allergy Asthma Immunol. 2022 May 20. pii: S1081-1206(22)00445.

  10. ALMUHIZI F, Fein M, Gabrielli S, Gilbert L, et al
    Allergic Reactions to the COVID-19 vaccine (ARCOV) study: the McGill University Health Center (MUHC) experience.
    Ann Allergy Asthma Immunol. 2022 May 21. pii: S1081-1206(22)00447.
    PubMed         Abstract available

  11. APPIAH MM, Haft MA, Kleinman E, Laborada J, et al
    Atopic Dermatitis: Review of Comorbidities and Therapeutics.
    Ann Allergy Asthma Immunol. 2022 May 21. pii: S1081-1206(22)00446.
    PubMed         Abstract available

  12. LIPWORTH DB, Stewart MK, Chan DR
    Pragmatic reappraisal of long acting muscarinic antagonists at steps 4/5 for persistent adult asthma: Invited Perspective article for Annals of Allergy, Asthma and Immunology.
    Ann Allergy Asthma Immunol. 2022 May 22. pii: S1081-1206(22)00449.

    Clinically relevant update on allergens!
    Ann Allergy Asthma Immunol. 2022;128:615-616.

  14. PALLER AS, Beck LA
    Bleach baths for atopic dermatitis: Evidence of efficacy but more data are needed.
    Ann Allergy Asthma Immunol. 2022;128:617-618.

  15. HUANG YC, Wu MC, Wei JC
    Comment on "Association between early life laxative exposure and risk of allergic diseases".
    Ann Allergy Asthma Immunol. 2022;128:737.

    Contact Dermatitis

  16. MIZUTANI H, Felmingham C, Palmer A, Tate B, et al
    Allergic Contact Cheilitis in Melbourne, Australia.
    Contact Dermatitis. 2022 May 24. doi: 10.1111/cod.14165.

  17. PUNCHIHEWA N, Palmer A, Nixon R
    Allergic contact dermatitis to Compositae: an Australian case series.
    Contact Dermatitis. 2022 May 23. doi: 10.1111/cod.14162.
    PubMed         Abstract available


  18. LUCAS R, Szklenar M, Mihaly J, Szegedi A, et al
    Plasma Levels of Bioactive Vitamin D and A5 Ligands Positively Correlate with Clinical Atopic Dermatitis Markers.
    Dermatology. 2022 May 24:1-8. doi: 10.1159/000524343.
    PubMed         Abstract available

    Eur Respir J

  19. WOEHLK C, Von Bulow A, Ghanizada M, Baastrup Sondergaard M, et al
    Allergen immunotherapy effectively reduces the risk of exacerbations and lower respiratory tract infections in both seasonal and perennial allergic asthma: a nationwide epidemiological study.
    Eur Respir J. 2022 May 26. pii: 13993003.00446-2022.
    PubMed         Abstract available

    Int Arch Allergy Immunol

  20. VALENT P, Hartmann K, Bonadonna P, Niedoszytko M, et al
    Mast Cell Activation Syndromes: Collegium Internationale Allergologicum Update 2022.
    Int Arch Allergy Immunol. 2022 May 23:1-13. doi: 10.1159/000524532.
    PubMed         Abstract available

  21. YOSHISUE H, Ito C, Okano M
    Clinical Characteristics, Health Care Resource Utilization, and Prescription Patterns of Japanese Patients with Physician-Diagnosed Allergic Rhinitis: A Secondary Use of Database Study.
    Int Arch Allergy Immunol. 2022 May 20:1-14. doi: 10.1159/000524740.
    PubMed         Abstract available

    J Allergy Clin Immunol

  22. PETERS RL, Guarnieri I, Tang MLK, Lowe AJ, et al
    The natural history of peanut and egg allergy in children up to age 6 years in the HealthNuts population-based longitudinal study.
    J Allergy Clin Immunol. 2022 May 10. pii: S0091-6749(22)00543.
    PubMed         Abstract available

    J Dermatol

  23. SALAVA A, Salo V, Remitz A
    Keratosis pilaris and filaggrin loss-of-function mutations in patients with atopic dermatitis - Results of a Finnish cross-sectional study.
    J Dermatol. 2022 May 26. doi: 10.1111/1346-8138.16477.
    PubMed         Abstract available

Thank you for your interest in scientific medicine.

AMEDEO Hypersensitivity Reaction is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.